PharmaBoardroom

Ufuk Kumrulu – Chairman, Polifarma

Polifarma is a Turkish pharma company dedicated to the hospital sector and biosimilars. Its chairman, Ufuk Kumrulu, explains how the company has…

Turkey: A Pharma Talent Hotbed

Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has compiled a strategic overview of…

Top 2021 Insights from Global Regulators

Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for…

Burak Dağlıoğlu – President, Investment Office of the…

The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines the country’s current economic…

Muzzafer Bal – CEO, Ali Raif

Muzaffer Bal, CEO of Ali Raif, a Turkish generics firm, highlights the company’s new investment in a manufacturing plant, their refusal to follow…

Süha Taşpolatoğlu – CEO, Abdi Ibrahim

Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s ambitious bet on biosimilars, their…

Hatice Öncel – CEO, Ilko Pharmaceuticals

Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel explains the company’s investment in…

Hamdi Akan – Head of the Executive Board, Clinical Research…

Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and barriers to become a clinical trials…

İsmail Yormaz – VP & Regional Director South-East,…

İsmail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has become a shining example of a…

How Pricing is Straining Turkish Pharma’s Sustainability

Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of universal healthcare coverage to over…

Building a Globally Competitive Innovation Ecosystem in Singapore

Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest some USD 20 billion over the next 5…

Şeyda Atadan Memiş – General Manager, Takeda Turkey

Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey at a pivotal moment when the Shire…

Tagged with EY